Form 4: AIM ImmunoTech COO Acquires Shares in Recent Transaction
SEC Form 4 Filing
Peter W. Rodino III, COO, Secretary, and General Counsel of AIM ImmunoTech Inc., reports acquiring shares of common stock in a transaction dated August 12, 2024.
Summary
- On August 12, 2024, Peter W. Rodino III, the COO, Secretary, and General Counsel of AIM ImmunoTech Inc., acquired 188,679 shares of common stock at a price of $0.265 per share.
- Following this transaction, Rodino directly owns 401,262 shares of AIM ImmunoTech Inc.
Sentiment
Score: 6
Explanation: The sentiment is neutral to slightly positive. While the document itself is simply a report of a transaction, insider buying is often seen as a positive sign.
Positives
- The COO's acquisition of shares could be interpreted as a positive signal, indicating confidence in the company's future prospects.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track management's alignment with shareholder interests.
Stakeholder Impact
- Shareholders may view the COO's share acquisition as a positive indicator of the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 08/12/2024 | Date of the transaction where Peter W. Rodino III acquired shares of common stock. |
Keywords
AIM ImmunoTech Inc., Rodino, share acquisition, Form 4, beneficial ownership, common stock
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.